Suppr超能文献

作为生物活性萜类化合物生产者的放线菌:当前趋势与专利

Actinomycetes as Producers of Biologically Active Terpenoids: Current Trends and Patents.

作者信息

Tarasova Ekaterina V, Luchnikova Natalia A, Grishko Victoria V, Ivshina Irina B

机构信息

Perm Federal Research Center, Ural Branch of the Russian Academy of Sciences, 13A Lenina Str., 614990 Perm, Russia.

Department of Microbiology and Immunology, Perm State University, 15 Bukirev Str., 614990 Perm, Russia.

出版信息

Pharmaceuticals (Basel). 2023 Jun 12;16(6):872. doi: 10.3390/ph16060872.

Abstract

Terpenes and their derivatives (terpenoids and meroterpenoids, in particular) constitute the largest class of natural compounds, which have valuable biological activities and are promising therapeutic agents. The present review assesses the biosynthetic capabilities of actinomycetes to produce various terpene derivatives; reports the main methodological approaches to searching for new terpenes and their derivatives; identifies the most active terpene producers among actinomycetes; and describes the chemical diversity and biological properties of the obtained compounds. Among terpene derivatives isolated from actinomycetes, compounds with pronounced antifungal, antiviral, antitumor, anti-inflammatory, and other effects were determined. Actinomycete-produced terpenoids and meroterpenoids with high antimicrobial activity are of interest as a source of novel antibiotics effective against drug-resistant pathogenic bacteria. Most of the discovered terpene derivatives are produced by the genus ; however, recent publications have reported terpene biosynthesis by members of the genera , , , , , , , , etc. It should be noted that the use of genetically modified actinomycetes is an effective tool for studying and regulating terpenes, as well as increasing productivity of terpene biosynthesis in comparison with native producers. The review includes research articles on terpene biosynthesis by between 2000 and 2022, and a patent analysis in this area shows current trends and actual research directions in this field.

摘要

萜类化合物及其衍生物(特别是萜类和杂萜类化合物)构成了最大的一类天然化合物,它们具有宝贵的生物活性,是很有前景的治疗剂。本综述评估了放线菌产生各种萜类衍生物的生物合成能力;报告了寻找新的萜类化合物及其衍生物的主要方法;确定了放线菌中最活跃的萜类化合物生产者;并描述了所获得化合物的化学多样性和生物学特性。在从放线菌中分离出的萜类衍生物中,确定了具有显著抗真菌、抗病毒、抗肿瘤、抗炎和其他作用的化合物。放线菌产生的具有高抗菌活性的萜类化合物和杂萜类化合物,作为有效对抗耐药病原菌的新型抗生素来源而受到关注。大多数已发现的萜类衍生物是由 属产生的;然而,最近的出版物报道了 属、 属、 属、 属、 属、 属、 属、 属等成员的萜类生物合成。应该指出的是,与天然生产者相比,使用基因改造的放线菌是研究和调节萜类化合物以及提高萜类生物合成产量的有效工具。该综述包括2000年至2022年间关于 萜类生物合成的研究文章,该领域的专利分析显示了该领域当前的趋势和实际研究方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c78/10301674/3966d77e6310/pharmaceuticals-16-00872-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验